Oncology ImagingArchives
Dosimetric comparison of scanned proton therapy and volumetric modulated arc therapy in isodose-prescribed stereotactic body radiotherapy for lung cancer
Oncology Imaging 1 min.
This study evaluated the feasibility of pencil beam scanning (PBS) proton therapy for stereotactic body radiotherapy using an isodose prescription in patients with isolated early-stage lung cancer, comparing dose-volume metrics with those of volumetric modulated arc therapy (VMAT). Treatment plans were...
ERS/ESTS/ESTRO/ESR/ESTI/EFOMP statement on management of incidental findings from low dose CT screening for lung cancer
Oncology Imaging 1 min.
Screening for lung cancer with low radiation dose computed tomography has a strong evidence base, is being introduced in several European countries and is recommended as a new targeted cancer screening programme. The imperative now is to ensure that implementation follows an evidence-based process that...
A rare primary mediastinal mesenchymal tumor diagnosed by endobronchial ultrasound (EBUS)
Oncology Imaging 2 min.
Mesenchymal tumors of the mediastinum are exceedingly rare, accounting for only approximately 2–6% of all mediastinal neoplasms [1]. Except for certain exceptions, mediastinal soft tissue tumors display histological and molecular features largely analogous to those of their counterparts in other...
Machine learning-DeepSurv prediction model integrating mpMRI radiomics and genomic biomarkers for BCR-free survival and tumor response in prostate radiotherapy
Oncology Imaging 1 min.
The purpose of this study was to design a radiogenomics machine learning-DeepSurv model for biochemical recurrence-free (BCR-free) survival and treatment response (TR) prediction for radiotherapy (RT) of prostate cancer (PCa). In this study, radiomic features were extracted from pre and post treatment...
Ultrasound for predicting pathological response to neoadjuvant chemotherapy in patients with breast cancer: a systematic review and meta-analysis
Oncology Imaging 4 min.
Breast cancer (BC) is the second most common malignant neoplasm globally, and it ranks fifth as a cause of death [1]. Neoadjuvant chemotherapy (NAC) can reduce patient’s primary tumor burden and the extent of nodal involvement, which may increase the likelihood of breast-conserving surgery and...
